myDNA Revenue and Competitors

South Yarra, VIC AUS

Location

N/A

Total Funding

Fitness

Industry

Estimated Revenue & Valuation

  • myDNA's estimated annual revenue is currently $7.5M per year.(i)
  • myDNA's estimated revenue per employee is $208,333

Employee Data

  • myDNA has 36 Employees.(i)
  • myDNA grew their employee count by -10% last year.

myDNA's People

NameTitleEmail/Phone
1
VP, Finance & Business OperationsReveal Email/Phone
2
Head ResearchReveal Email/Phone
3
Chief Commercial Officer (CCO)Reveal Email/Phone
4
Director OperationsReveal Email/Phone
5
Scientific Director, NutrigenomicsReveal Email/Phone
6
Agile Project ManagerReveal Email/Phone
7
Customer Engagement ManagerReveal Email/Phone
8
Full Stack DeveloperReveal Email/Phone
9
Marketing Content CoordinatorReveal Email/Phone
10
Junior Business AnalystReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M36-10%N/AN/A
Add Company

What Is myDNA?

myDNA is a genetic interpretation service. We help people to make better health, wellness and lifestyle decisions. myDNA is headquartered in Melbourne and has operations in Australia, NZ, USA, Canada and the UK. The company was founded by Associate Professor Les Sheffield, who has been at the forefront of genetic research since the 1980s. Scientific credibility and a focus on evidence-based, peer-reviewed research is fundamental to our ongoing success. Our clinical team includes pharmacologists, molecular and clinical geneticists, researchers, genetic counselors, nutritionists and dietitians. The company has built a National Association of Testing Authorities (NATA) accredited laboratory and is an Organisational Member of the Global Alliance for Genomics and Health.

keywords:N/A

N/A

Total Funding

36

Number of Employees

$7.5M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M4111%N/A
#2
$8M599%N/A
#3
$13.3M5913%N/A
#4
$11.1M609%N/A
#5
$11.7M6251%N/A